XIST Induced by JPX Suppresses Hepatocellular Carcinoma by Sponging miR-155-5p
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: The influence of X-inactive specific transcript (XIST) and X-chromosome inactivation associated long non-coding RNAs (lncRNAs) just proximal to XIST (JPX) on hepatocellular carcinoma (HCC) remains controversial in light of previous reports, which the present study aimed to verify. Materials and Methods: The DIANA lncRNA-microRNA (miRNA) interaction database was used to explore miRNA interactions with JPX or XIST. JPX, XIST, and miR-155-5p expression levels in paired HCC specimens and adjacent normal tissue were analyzedby RT-qPCR. Interaction between XIST and miR-155-5p was verified by dual luciferase reporter assay. Expression levels of miR-155-5p and its known target genes, SOX6 and PTEN, were verified by RT-qPCR and Western blot in HepG2 cells with or withoutXIST knock-in. The potential suppressive role of XIST and JPX on HCC was verified by cell functional assays and tumor formationassay using a xenograft model. Results: JPX and XIST expression was significantly decreased in HCC pathologic specimens, compared to adjacent tissue, which correlated with HCC progression and increased miR-155-5p expression. Dual luciferase reporter assay revealed XIST as a direct target of miR-155-5p. XIST knock-in significantly reduced miR-155-5p expression level and increased that of SOX6 and PTEN, while significantly inhibiting HepG2 cell growth in vitro, which was partially reversed by miR-155-5p mimic transfection. JPX knock-in significantly increased XIST expression and inhibited HepG2 cell growth in vitro or tumor formation in vivo in a XIST dependent manner. Conclusion: JPX and XIST play a suppressive role in HCC. JPX increases expression levels of XIST in HCC cells, which suppresses HCC development by sponging the cancer promoting miR-155-5p.
Abstract
Purpose: The influence of X-inactive specific transcript (XIST) and X-chromosome inactivation associated long non-coding RNAs (lncRNAs) just proximal to XIST (JPX) on hepatocellular carcinoma (HCC) remains controversial in light of previous reports, which the present study aimed to verify. Materials and Methods: The DIANA lncRNA-microRNA (miRNA) interaction database was used to explore miRNA interactions with JPX or XIST. JPX, XIST, and miR-155-5p expression levels in paired HCC specimens and adjacent normal tissue were analyzedby RT-qPCR. Interaction between XIST and miR-155-5p was verified by dual luciferase reporter assay. Expression levels of miR-155-5p and its known target genes, SOX6 and PTEN, were verified by RT-qPCR and Western blot in HepG2 cells with or withoutXIST knock-in. The potential suppressive role of XIST and JPX on HCC was verified by cell functional assays and tumor formationassay using a xenograft model. Results: JPX and XIST expression was significantly decreased in HCC pathologic specimens, compared to adjacent tissue, which correlated with HCC progression and increased miR-155-5p expression. Dual luciferase reporter assay revealed XIST as a direct target of miR-155-5p. XIST knock-in significantly reduced miR-155-5p expression level and increased that of SOX6 and PTEN, while significantly inhibiting HepG2 cell growth in vitro, which was partially reversed by miR-155-5p mimic transfection. JPX knock-in significantly increased XIST expression and inhibited HepG2 cell growth in vitro or tumor formation in vivo in a XIST dependent manner. Conclusion: JPX and XIST play a suppressive role in HCC. JPX increases expression levels of XIST in HCC cells, which suppresses HCC development by sponging the cancer promoting miR-155-5p.
참고문헌 (41)
- Tay Y, "The multilayered complexity of ceRNA crosstalk and competition", Nature, 505, pp.344~352 (2014)[DOI]
- Karreth FA, "ceRNA cross-talk in cancer: when cebling rivalries go awry", Cancer Discov, 3, pp.1113~1121 (2013)[DOI]
- Yuan SX, "Long noncoding RNA DANCR increases stemness features of hepatocellular carcinoma by derepression of CTNNB1", Hepatology, 63, pp.499~511 (2016)[DOI]
- Fu WM, "Hotair mediates hepatocarcinogenesis through suppressing miRNA-218 expression and activating P14 and P16 signaling", J Hepatol, 63, pp.886~895 (2015)[DOI]
- Cui M, "Long noncoding RNA HULC modulates abnormal lipid metabolism in hepatoma cells through an miR-9-mediated RXRA signaling pathway", Cancer Res, 75, pp.846~857 (2015)[DOI]
- Ma X, "X-inactive-specific transcript of peripheral blood cells is regulated by exosomal Jpx and acts as a biomarker for female patients with hepatocellular carcinoma", Ther Adv Med Oncol, 9, pp.665~677 (2017)[DOI]
- Ma W, "Downregulation of long non-coding RNAs JPX and XIST is associated with the prognosis of hepatocellular carcinoma", Clin Res Hepatol Gastroenterol, 41, pp.163~170 (2017)[DOI]
- Mo Y, "Long non-coding RNA XIST promotes cell growth by regulating miR-139-5p", PDK1, Tumour Biol, pp.2017, 39[DOI]
- Li C, "Long non-coding RNA XIST promotes TGF-<TEX>${\beta}$<", TEX>-induced epithelial-mesenchymal transition by regulating miR-367, Cancer Lett, pp.2018, 418[DOI]
- Zhang Q, "XIST promotes gastric cancer (GC) progression through TGF-<TEX>${\beta}1$<", TEX> via targeting miR-185, 2018, pp.119, 2787~2796
- Du Y, "LncRNA XIST acts as a tumor suppressor in prostate cancer through sponging miR-23a to modulate RKIP expression", Oncotarget, 8, pp.94358~94370 (2017)
- Xiao C, "The XIST noncoding RNA functions independently of BRCA1 in X inactivation", Cell, 128, pp.977~989 (2007)[DOI]
- Liu X, "Long non-coding RNA XIST regulates miR-137-EZH2 axis to promote tumor metastasis in colorectal cancer", Oncol Res (2018)[DOI]
- Huang YS, "Xist reduction in breast cancer upregulates AKT phosphorylation via HDAC3-mediated repression of PHLPP1 expression", Oncotarget, 7, pp.43256~43266 (2016)
- Yan XL, "Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis", Hepatology, 57, pp.2274~2286 (2013)[DOI]
- Wang B, "Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL", 6 mice, 2009, pp.50, 1152~1161
- Chen G, "miR-155-5p modulates malignant behaviors of hepatocellular carcinoma by directly targeting CTHRC1 and indirectly regulating GSK-<TEX>$3{\beta}$<", TEX>-involved Wnt, TEX>-catenin signaling, pp.Cancer Cell Int, 2017[DOI]
- Fu X, "MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K", Akt pathway, 2017, pp.108, 620~631
- Wong CM, "Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications", Nat Rev Gastroenterol Hepatol, 15, pp.137~151 (2018)[DOI]
- Pintacuda G, "Function by structure: spotlights on Xist long non-coding RNA", Front Mol Biosci, 4, pp.90~ (2017)[DOI]
- Robert Finestra T, "X chromosome inactivation: silencing, topology and reactivation", Curr Opin Cell Biol, 46, pp.54~61 (2017)[DOI]
- Xing Y, "CANT1 lncRNA triggers efficient therapeutic efficacy by correcting aberrant lncing cascade in malignant uveal melanoma", Mol Ther, 25, pp.1209~1221 (2017)[DOI]
- Yildirim E, "Xist RNA is a potent suppressor of hematologic cancer in mice", Cell, 152, pp.727~742 (2013)[DOI]
- Jiang H, "Knockdown of long non-coding RNA XIST inhibits cell viability and invasion by regulating miR-137", PXN axis in non-small cell lung cancer, 2018, pp.111, 623~631
- Zhang R, "Long non-coding RNA XIST regulates PDCD4 expression by interacting with miR-21-5p and inhibits osteosarcoma cell growth and metastasis", Int J Oncol, 51, pp.1460~1470 (2017)[DOI]
- Lin C, "Long noncoding RNA in cancer: wiring signaling circuitry", Trends Cell Biol, 28, pp.287~301 (2018)[DOI]
- Bhan A, "Long noncoding RNA and cancer: a new paradigm", Cancer Res, 77, pp.3965~3981 (2017)[DOI]
- Chang S, "Long non-coding RNA XIST regulates PTEN expression by sponging miR-181a and promotes hepatocellular carcinoma progression", BMC Cancer, 17, pp.248~ (2017)[DOI]
- Sun S, "Jpx RNA activates Xist by evicting CTCF", Cell, 153, pp.1537~1551 (2013)[DOI]
- Tian D, "The long noncoding RNA, Jpx, is a molecular switch for X chromosome inactivation", Cell, 143, pp.390~403 (2010)[DOI]
- Romito A, "Origin and evolution of the long noncoding genes in the X-inactivation center", Biochimie, 93, pp.1935~1942 (2011)[DOI]
- Chow JC, "Characterization of expression at the human XIST locus in somatic, embryonal carcinoma, and transgenic cell lines", Genomics, 82, pp.309~322 (2003)[DOI]
- Paraskevopoulou MD, "DIANA-LncBase v2: indexing microRNA targets on non-coding transcripts", Nucleic Acids Res, 44, pp.D231~D238 (2016)[DOI]
- Wang M, "The role of mmu-miR-155-5p-NF-<TEX>${\kappa}B$<", TEX> signaling in the education of bone marrow-derived mesenchymal stem cells by gastric cancer cells, 2018, pp.7, 856~868
- Zhang Y, "Prognostic value of microRNAs in hepatocellular carcinoma: a meta-analysis", Oncotarget, 8, pp.107237~107257 (2017)
- Zhang L, "MicroRNA-155 promotes tumor growth of human hepatocellular carcinoma by targeting ARID2", Int J Oncol, 48, pp.2425~2434 (2016)[DOI]
- Xie Q, "Aberrant expression of microRNA 155 may accelerate cell proliferation by targeting sex-determining region Y box 6 in hepatocellular carcinoma", Cancer, 118, pp.2431~2442 (2012)[DOI]
- Liu F, "Long noncoding RNA FTX inhibits hepatocellular carcinoma proliferation and metastasis by binding MCM2 and miR-374a", Oncogene, 35, pp.5422~5434 (2016)[DOI]
- Zhuang LK, "MicroRNA-92b promotes hepatocellular carcinoma progression by targeting Smad7 and is mediated by long non-coding RNA XIST", Cell Death Dis, 7, pp.e2203~ (2016)[DOI]
- Kristiansen M, "High incidence of skewed X chromosome inactivation in young patients with familial non-BRCA1", BRCA2 breast cancer, 2005, pp.42, 877~880
- Manoukian S, "X chromosome inactivation pattern in BRCA gene mutation carriers", Eur J Cancer, 49, pp.1136~1141 (2013)[DOI]